Aptose to Participate in Upcoming Investor Conferences, Host Key Opinion Leader Event, and Present Data at the Upcoming ASH Meeting

Nov 20, 2018 7:05am EST

Aptose Reports Results for the Third Quarter Ended September 30, 2018

Nov 06, 2018 4:05pm EST

Aptose to Present New CG-806 Data at the 2018 ASH Annual Meeting

Nov 01, 2018 9:26am EDT

Aptose to Release Third Quarter Ended September 30, 2018 Financial Results on November 6, 2018

Oct 23, 2018 7:05am EDT

Aptose Biosciences and CrystalGenomics Announce Issuance of European Patent for CG-806

Sep 27, 2018 7:05am EDT

Aptose to Present at Upcoming Investor Conferences in October 2018

Sep 25, 2018 7:05am EDT

Aptose to Present at Upcoming Investor Conferences in September 2018

Aug 29, 2018 7:05am EDT

Aptose Announces Appointment of Carol Ashe to Board of Directors

Aug 15, 2018 7:05am EDT

Aptose Reports Results for the Second Quarter Ended June 30, 2018

Aug 07, 2018 4:18pm EDT

Aptose Biosciences to Present at Canaccord Genuity 38th Annual Growth Conference

Aug 02, 2018 7:05am EDT